MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2

February 2020
European Review for Medical & Pharmacological Sciences;2020, Vol. 24 Issue 3, p1177
Academic Journal
OBJECTIVE: The aim of this study was to investigate whether microRNA-625-3p participated in the malignant progression of gastric cancer and inhibited GCa metastasis by regulating EZH2 (Enhancer of zeste homolog 2). PATIENTS AND METHODS: Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) was performed to examine the expression of microRNA- 625-3p in 36 pairs of GCa tissues and para-cancerous tissues. The interplay between microRNA-625-3p level and clinical indexes or prognosis of GCa patients was analyzed. MicroRNA- 625-3p mimics and inhibitors, as well as their negative controls, were transfected into GCa cell lines to establish microRNA-625-3p overexpression and down-regulation models in vitro, respectively. QRT-PCR was applied to further verify the transfection efficiency. Cell counting kit-8 (CCK-8), colony formation, and transwell assays were performed to analyze the impact of microRNA-625-3p on the proliferative and invasiveness abilities of GCa AGS and SGC-7901 cells. Finally, the regulatory mechanism of microRNA-625-3p on the downstream gene EZH2 was explored by cell reverse experiment. RESULTS: QRT-PCR results revealed that microRNA- 625-3p expression level in GCa tissues was remarkably lower than that of adjacent tissues, and the difference was statistically significant (p<0.05). Compared with patients with high expression of microRNA-625-3p, the incidence of lymph node or distant metastasis was significantly higher in patients with low expression of miR-625- 3p, whereas the overall survival rate was lower (p<0.05). Compared with GCa cells in NC inhibitor group, the proliferative ability and invasiveness of cells in microRNA-625-3p inhibitor group were remarkably promoted (p<0.05). However, the opposite results were observed in microRNA-625-3p mimics group. Our findings further demonstrated that the expression of EZH2 increased remarkably in GCa cell lines and tissues (p<0.05). Meanwhile, its expression level was negatively correlated with microRNA-625-3p level. Cell reverse experiment showed that EZH2 could offset the influence of microRNA-625-3p on the proliferation and metastasis GCa cells, thereby affecting the malignant progression of GCa. CONCLUSIONS: MicroRNA-625-3p was remarkably correlated with lymph node or distant metastasis and poor prognosis of GCa patients. In addition, microRNA-625-3p might inhibit the malignant progression of GCa via modulating EZH2.


Related Articles

  • Two rare cases of node-positive differentiated gastric cancer despite their infiltration to sm1, their small size, and lack of lymphatic invasion into the submucosal layer. Nagano, Hideki; Ohyama, Shigekazu; Fukunaga, Tetsu; Hiki, Naoki; Seto, Yasuyuki; Yamaguchi, Toshiharu; Kato, Yo; Yamaguchi, Akio // Gastric Cancer;Mar2008, Vol. 11 Issue 1, p53 

    Early gastric cancer without lymph node metastasis has been reported after the analysis of many cases, and a consensus has been reached about this condition. We report two cases of node-positive differentiated sm1 gastric cancer without lymphatic invasion into the submucosal layer. Case 1 was a...

  • Correlation between the current TNM staging and long-term survival after curative D1 lymphadenectomy for stomach cancer. Abbas, Saleh M.; Booth, M. W. // Langenbeck's Archives of Surgery;Sep2005, Vol. 390 Issue 4, p294 

    Background and aims: This study aims to assess the tumour-related factors that influence long-term survival after curative gastrectomy with standard D1 lymphadenectomy for patients with stomach cancer. Patients and methods: Patients who had undergone curative gastrectomy for carcinoma of the...

  • Comparison of Four Staging Systems of Lymph Node Metastasis in Gastric Cancer. Ming Zhang; Guanyu Zhu; Yan Ma; Yingwei Xue // World Journal of Surgery;Nov2009, Vol. 33 Issue 11, p2383 

    The classification of lymph node metastasis in patients with gastric cancer is still controversial. Our aim was to evaluate the relative merits of four staging systems of lymph node metastasis. In our study, the nodal status was classified according to the 5th edition of the tumor node...

  • Can Modified Dukes' Classification be Used in Gastric Cancer Staging? ÖZgüç, Halil; Öztürk, Ersin; Kirdak, Türkay; Yercİ, ÖMer; Sönmez, Yalçın; BaǦçivan, Erol; Korun, Nusret // Turkish Journal of Medical Sciences;2006, Vol. 36 Issue 5, p271 

    Aim: Dukes' staging system is a simple system used widely in the staging of colorectal cancer. This study was designed to analyze the applicability of the modified Dukes' classification system in gastric cancer cases. Methods: The prognostic factors affecting survival in 139 gastric cancer cases...

  • The predictive factors for lymph node metastasis in early gastric cancer: A clinical study. Yinzhong Wang // Pakistan Journal of Medical Sciences;Nov/Dec2015, Vol. 31 Issue 6, p1437 

    Objective: To detect the clinicopathological factors associated with lymph node metastases in early gastric cancer. Methods: We retrospectively evaluated the distribution of metastatic nodes in 198 patients with early gastric cancer treated in our hospital between May 2008 and January 2015, the...

  • Depth-predicting score for differentiated early gastric cancer. Abe, Seiichiro; Oda, Ichiro; Shimazu, Taichi; Kinjo, Tetsu; Tada, Kazuhiro; Sakamoto, Taku; Kusano, Chika; Gotoda, Takuji // Gastric Cancer;Mar2011, Vol. 14 Issue 1, p35 

    Background: Intramucosal and minute submucosal (M-SM1; <500 μm in depth) differentiated gastric cancers, which have a negligible risk of lymph node metastasis, are the targets for endoscopic resection. However, there have been few reports about the endoscopic distinction between these cancers...

  • Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer. Ueda, Kentaro; Iwahashi, Makoto; Nakamori, Mikihito; Nakamura, Masaki; Naka, Teiji; Ishida, Koichiro; Ojima, Toshiyasu; Yamaue, Hiroki // Langenbeck's Archives of Surgery;Sep2009, Vol. 394 Issue 4, p647 

    Whether or not a synchronous resection of liver metastases from gastric cancer provides a survival benefit has been a key issue. We identify the significant prognostic factors and clarify the beneficial effect on the survival of liver surgical treatment. We reviewed 72 patients who underwent a...

  • Multicenter study evaluating the clinical performance of the OSNA assay for the molecular detection of lymph node metastases in gastric cancer patients. Kumagai, Koshi; Yamamoto, Noriko; Miyashiro, Isao; Tomita, Yasuhiko; Katai, Hitoshi; Kushima, Ryoji; Tsuda, Hitoshi; Kitagawa, Yuko; Takeuchi, Hiroya; Mukai, Makio; Mano, Masayuki; Mochizuki, Hidetaka; Kato, Yo; Matsuura, Nariaki; Sano, Takeshi // Gastric Cancer;Apr2014, Vol. 17 Issue 2, p273 

    Background: The accurate diagnosis of lymph node (LN) metastasis is important for making treatment decisions for gastric cancer patients. This multicenter study evaluated the clinical performance of the one-step nucleic acid amplification (OSNA) assay (Sysmex Corp.), an automated system that...

  • Significance of occult neoplastic cells on tumor metastasis: a case report of gastric cancer. Sato, Shinkichi; Mukai, Masaya // Diagnostic Pathology;2010, Vol. 5, p14 

    Background: Occult neoplastic cells (ONCs) are the tumor cells floating in the lymph node sinuses, distant from the primary tumor, and supposed to be one of most reliable marker of prognosis. Methods: We report here the case of a 52-year-old woman with a gastric cancer associated by numerous...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics